ALBIREO PHARMA INC - COMMON STOCK (ALBO)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COMMON STOCK
Total 13F shares
17,754,471
Share change
+1,226,815
Total reported value
$352,558,617
Put/Call ratio
28%
Price per share
$19.86
Number of holders
96
Value change
+$18,502,559
Number of buys
48
Number of sells
54

Institutional Holders of ALBIREO PHARMA INC - COMMON STOCK (ALBO) as of Q2 2022

As of 30 Jun 2022, ALBIREO PHARMA INC - COMMON STOCK (ALBO) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,754,471 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, FEDERATED HERMES, INC., STATE STREET CORP, Chicago Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, TANG CAPITAL MANAGEMENT LLC, ArrowMark Colorado Holdings LLC, and Decheng Capital Management III (Cayman), LLC. This page lists 96 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.